Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−98.51 MXN
−11.81 B MXN
69.97 M MXN
116.02 M
About Arrowhead Pharmaceuticals, Inc.
Sector
Industry
CEO
Christopher Richard Anzalone
Website
Headquarters
Pasadena
Founded
1989
FIGI
BBG00TSG2G39
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange ARROWHEAD PHARMACEUTICALS, INC stocks are traded under the ticker ARWR.
ARWR stock has risen by 4.89% compared to the previous week, the month change is a 4.89% rise, over the last year ARROWHEAD PHARMACEUTICALS, INC has showed a 4.89% increase.
We've gathered analysts' opinions on ARROWHEAD PHARMACEUTICALS, INC future price: according to them, ARWR price has a max estimate of 1,630.99 MXN and a min estimate of 489.30 MXN. Watch ARWR chart and read a more detailed ARROWHEAD PHARMACEUTICALS, INC stock forecast: see what analysts think of ARROWHEAD PHARMACEUTICALS, INC and suggest that you do with its stocks.
ARWR stock is 4.89% volatile and has beta coefficient of 1.80. Track ARROWHEAD PHARMACEUTICALS, INC stock price on the chart and check out the list of the most volatile stocks — is ARROWHEAD PHARMACEUTICALS, INC there?
Today ARROWHEAD PHARMACEUTICALS, INC has the market capitalization of 48.21 B, it has increased by 40.97% over the last week.
Yes, you can track ARROWHEAD PHARMACEUTICALS, INC financials in yearly and quarterly reports right on TradingView.
ARROWHEAD PHARMACEUTICALS, INC is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
ARWR earnings for the last quarter are −26.80 MXN per share, whereas the estimation was −22.08 MXN resulting in a −21.38% surprise. The estimated earnings for the next quarter are −8.45 MXN per share. See more details about ARROWHEAD PHARMACEUTICALS, INC earnings.
ARROWHEAD PHARMACEUTICALS, INC revenue for the last quarter amounts to 0.00 MXN, despite the estimated figure of 1.09 B MXN. In the next quarter, revenue is expected to reach 1.52 B MXN.
ARWR net income for the last quarter is −3.36 B MXN, while the quarter before that showed −3.13 B MXN of net income which accounts for −7.26% change. Track more ARROWHEAD PHARMACEUTICALS, INC financial stats to get the full picture.
No, ARWR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 3, 2025, the company has 609.00 employees. See our rating of the largest employees — is ARROWHEAD PHARMACEUTICALS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARROWHEAD PHARMACEUTICALS, INC EBITDA is −11.48 B MXN, and current EBITDA margin is −16.40 K%. See more stats in ARROWHEAD PHARMACEUTICALS, INC financial statements.
Like other stocks, ARWR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARROWHEAD PHARMACEUTICALS, INC stock right from TradingView charts — choose your broker and connect to your account.